Cover Image

Disparities in elexacaftor/tezacaftor/ivacaftor initiation in the US cystic fibrosis population

Fuente: Wiley Open Access

Saved in:

Bibliographic Details
Main Authors:	Kamyron Jordan, Timothy Vigers, Jennifer L. Taylor‐Cousar, Scott D. Sagel
Format:	Artículo Open Access
Published:	Wiley 2024
Subjects:	Pediatric Pulmonology
Online Access:	Acceder al recurso
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Severe mental health changes in patients with cystic fibrosis on elexacaftor/tezacaftor/ivacaftor therapy
by: Cameron J. McKinzie, et al.
Published: (2024)

Mental health, sleep, and respiratory health after initiating elexacaftor/tezacaftor/ivacaftor treatment in children with cystic fibrosis
by: Hiep Pham, et al.
Published: (2024)

A survey of cystic fibrosis physicians' views on lung transplant referral in the era of elexacaftor/tezacaftor/ivacaftor
by: Nora Burdis, et al.
Published: (2024)

Effectiveness and safety of elexacaftor/tezacaftor/ivacaftor treatment in children aged 6‐11 years with cystic fibrosis in a real‐world setting
by: Valeria Daccò, et al.
Published: (2024)

Medication utilization and lung function changes after initiation of treatment with elexacaftor/tezacaftor/ivacaftor
by: Richard De Vuyst, et al.
Published: (2024)

Diagnosis and treatment of ADHD in pediatric patients during the first year of elexacaftor/tezacaftor/ivacaftor
by: Kimberly Pasley, et al.
Published: (2024)

Clinical effectiveness of elexacaftor/tezacaftor/ivacaftor in a man with A559T and 3120+1G>CFTR variants
by: Emily Mitchell, et al.
Published: (2024)

Clinical evidence of pancreatic recovery in children with cystic fibrosis on ivacaftor
by: Sydney Walker, et al.
Published: (2024)

Impact of Home Collection and Shipping of Respiratory Specimens on Bacterial Pathogen Detection in Children With Cystic Fibrosis
by: Jordana E. Hoppe, et al.
Published: (2025)

Home Cough Monitoring Reveals Higher Nighttime Cough Burden in Children With Cystic Fibrosis Compared With Healthy Children
by: Lilah D. Melzer, et al.
Published: (2025)

The foregut in cystic fibrosis
by: Christopher Vélez, et al.
Published: (2024)

Prevalence of cannabidiol use in persons with cystic fibrosis
by: Emma M. Tillman, et al.
Published: (2024)

The future of cystic fibrosis: A global perspective
by: Felix Ratjen
Published: (2024)

Time to be blunt: Substance use in cystic fibrosis
by: Sanaz Vaziri, et al.
Published: (2024)

Impact of elexacaftor/tezacaftor/ivacaftor on biomarkers of cystic fibrosis hepatobiliary involvement in the PUSH study
by: Wen Ye, et al.
Published: (2025)

Lung T1 MRI assessments in children with mild cystic fibrosis lung disease
by: Clement L. Ren, et al.
Published: (2024)

Predicting weight gain in patients with cystic fibrosis on triple combination modulator
by: Kelly L. Stewart, et al.
Published: (2024)

Nutrition and behavioral health in cystic fibrosis: Eating and body image
by: Emma R. Lyons, et al.
Published: (2024)

Codevelopment of a model of care for adults living with cystic fibrosis‐related diabetes
by: Shanal Kumar, et al.
Published: (2024)

The gastrointestinal microbiome, small bowel bacterial overgrowth, and microbiome modulators in cystic fibrosis
by: Nicole Green, et al.
Published: (2024)

Me, myself, and I: A systematic review of cystic fibrosis and self‐concept
by: Maggie Harrigan, et al.
Published: (2024)

Validation of the Integrated Palliative Care Outcome Scale (IPOS) in adults with cystic fibrosis
by: Anna M. Georgiopoulos, et al.
Published: (2024)

BMI increase during early childhood in boys with cystic fibrosis and early adrenarche
by: Gizem Tamer, et al.
Published: (2024)

Overnutrition in persons with cystic fibrosis on modulator therapy and the relationship to obstructive sleep apnea
by: Aesha M. Jobanputra, et al.
Published: (2024)

Effects on growth, weight and body composition after CFTR modulators in children with cystic fibrosis
by: CM. López Cárdenes, et al.
Published: (2024)

Evaluation of otorhinolaryngologic, audiologic, and genetic findings in children with cystic fibrosis: A tertiary care experience
by: Halime Nayır Büyükşahin, et al.
Published: (2024)

Preferences and perspectives regarding telehealth exercise interventions for adults with cystic fibrosis: A qualitative study
by: Megan Poulsen, et al.
Published: (2024)

Successful treatment of Stenotrophomonas maltophilia with ceftazidime‐avibactam and aztreonam in an individual with cystic fibrosis: A case report
by: Stephanie Duehlmeyer, et al.
Published: (2024)

Clinical outcomes at 9–10 years of age in children born with cystic fibrosis transmembrane conductance regulator related metabolic syndrome
by: Brian J. Carroll, et al.
Published: (2024)

Comparison of particles in exhaled air and multiple breath washout for assessment of small airway function in children with cystic fibrosis
by: Annelies M. Zwitserloot, et al.
Published: (2024)

Diabetes remission in adults with cystic fibrosis commenced on Elexacaftor/Tezacaftor/Ivacaftor: A single center case‐series
by: Shanal Kumar, et al.
Published: (2024)

Factors associated with pulmonary function decline of patients in the cystic fibrosis registry of Turkey: A retrospective cohort study
by: Nagehan Emiralioğlu, et al.
Published: (2024)

Adding fuel to the fire: The growing case for global access to cystic fibrosis transmembrane conductance regulator modulator therapy
by: Brenda M. Morrow, et al.
Published: (2024)

Nebulized granulocyte macrophage‐colony stimulating factor to stabilize lung function in nontuberculous mycobacteria pulmonary disease in cystic fibrosis
by: Colette Biro, et al.
Published: (2024)

Lung clearance index (LCI2.5) changes after initiation of Elexacaftor/Tezacaftor/Ivacaftor in children with cystic fibrosis aged between 6 and 11 years: The “real‐world” differs from trial data
by: Don S. Urquhart, et al.
Published: (2024)

The rebound effect: Reoccurrence of nasal polyps following discontinuation of a CFTR modulator in a patient with cystic fibrosis sinus disease
by: Brittany A. Wright, et al.
Published: (2024)

A comparison of aminoglycoside antibiotic serum concentrations collected by peripheral veins and peripherally inserted central catheters in adults with cystic fibrosis
by: Sabrina J. Sherwood, et al.
Published: (2024)

Implementation and outcomes of a quality improvement project to systematically assess the gross motor skills in school‐aged children with cystic fibrosis
by: Abby Good, et al.
Published: (2024)

New York cystic fibrosis consortium newborn screening quality improvement: Development and implementation of a statewide consensus recommendations for management of infants with CFTR‐related metabolic syndrome
by: Saroj Choudhary, et al.
Published: (2024)

Improving implementation and team communication by integrating a cystic fibrosis transition readiness (CF R.I.S.E.) program into electronic health records
by: Catherine Enochs, et al.
Published: (2024)